No abstract available
Keywords:
ACE, angiotensin-converting enzyme; ACEI, angiotensin-converting enzyme inhibitors; ACEI/ARB; ARB, angiotensin receptor blockers; COVID-19; COVID-19, coronavirus disease 2019; Digestive System; GI, gastrointestinal; Liver Injury.
MeSH terms
-
Aged
-
Angiotensin Receptor Antagonists / therapeutic use*
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
-
Betacoronavirus*
-
COVID-19
-
China
-
Coronavirus Infections / complications*
-
Coronavirus Infections / diagnosis
-
Coronavirus Infections / mortality*
-
Female
-
Gastrointestinal Diseases / epidemiology*
-
Humans
-
Hypertension / drug therapy
-
Length of Stay
-
Male
-
Middle Aged
-
Pandemics
-
Pneumonia, Viral / complications*
-
Pneumonia, Viral / diagnosis
-
Pneumonia, Viral / mortality*
-
Retrospective Studies
-
SARS-CoV-2
-
Survival Rate
-
Symptom Assessment
Substances
-
Angiotensin Receptor Antagonists
-
Angiotensin-Converting Enzyme Inhibitors